![Nigel Raymond Stevenson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nigel Raymond Stevenson
Directeur Technique/Scientifique/R&D chez
VIVOS INC.
Profil
Nigel Raymond Stevenson is the founder of Exubrion Therapeutics, Inc. where he held the title of Chief Operating Officer starting in 2019.
He is also the founder of TcNet LLC.
Currently, Dr. Stevenson is the Chief Science Officer at Vivos, Inc. In the past, he has worked as the Vice President-Production & Research at Theragenics Corp., the Chief Operating Officer at Clear Vascular, Inc., the Chief Operating Officer at Trace Life Sciences, Inc., and the Head-Isotope Production & Research at Tri University Mezzon Facility.
Dr. Stevenson obtained his doctorate degree from the University of London in 1983.
Postes actifs de Nigel Raymond Stevenson
| Sociétés | Poste | Début |
|---|---|---|
| VIVOS INC. | Directeur Technique/Scientifique/R&D | - |
TcNet LLC | Directeur Général | - |
Exubrion Therapeutics , Inc.
 Exubrion Therapeutics , Inc. Medical SpecialtiesHealth Technology Develops electron therapeutic veterinary devices | Fondateur | 01/01/2019 |
Anciens postes connus de Nigel Raymond Stevenson
| Sociétés | Poste | Fin |
|---|---|---|
Tri University Mezzon Facility
 Tri University Mezzon Facility Miscellaneous Commercial ServicesCommercial Services Provides subatomic physics laboratories | Corporate Officer/Principal | - |
Trace Life Sciences, Inc.
 Trace Life Sciences, Inc. Chemicals: SpecialtyProcess Industries Manufactures radiochemical, radiopharmaceuticals and research isotopes for medical imaging and therapy | Directeur des opérations | - |
Theragenics Corp.
 Theragenics Corp. Medical SpecialtiesHealth Technology Develops and manufactures radioisotopes and brachytherapy seeds | Corporate Officer/Principal | - |
Clear Vascular, Inc.
 Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Develops radionuclide products for multiple clinical applications | Directeur des opérations | - |
Formation de Nigel Raymond Stevenson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Theragenics Corp.
Theragenics Corp. Medical SpecialtiesHealth Technology Develops and manufactures radioisotopes and brachytherapy seeds | Health Technology |
Vivos, Inc.
 Vivos, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes medical isotopes | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clear Vascular, Inc.
Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Develops radionuclide products for multiple clinical applications | Health Technology |
Trace Life Sciences, Inc.
Trace Life Sciences, Inc. Chemicals: SpecialtyProcess Industries Manufactures radiochemical, radiopharmaceuticals and research isotopes for medical imaging and therapy | Process Industries |
Tri University Mezzon Facility
Tri University Mezzon Facility Miscellaneous Commercial ServicesCommercial Services Provides subatomic physics laboratories | Commercial Services |
TcNet LLC | |
Exubrion Therapeutics , Inc.
Exubrion Therapeutics , Inc. Medical SpecialtiesHealth Technology Develops electron therapeutic veterinary devices | Health Technology |
